Back to search

National and Kapodistrian University of Athens

Παράγοντες (πλην των κυτταρογενετικών) με σημασία για τη συμπεριφορά της Χ.Λ.Λ.

Abstract

dc:description

Chronic Lymphocytic leukemia is an indolent leukemic B-cell lymphoproliferative disorder involving peripheral blood, bone marrow, spleen and lymph nodes. Patients usually enjoy a favorable outcome as the majority of them remain asymptomatic for years without needing treatment. However, some patients have a more aggressive course and shorter survival; clinical manifestations, when present, include anaemia, peripheral lymphadenopathy, splenomegaly and autoimmune manifestations. Treatment should be immediately initiated in the presence of a lymphocytic doubling time of less than 6 months, very enlarged or rapidly growing lymph nodes or spleen, anaemia, thrombocytopenia and B symptoms. For symptomatic patients adverse prognostic factors include classical staging ( according to Rai or Binet ), unmutated VH genes, ZAP-70 and CD-38 expression, cytogenetic alterations such as deletion of 11q, deletion of 17p, and/or presence of TP53 mutation. Additional prognostic factors are needed for asymptomatic patients to predict whether they will remain stable for years or not, so this was the purpose of our study. Serum free light chains ( sFLC ) are the most commonly detected paraprotein in CLL and were recently proposed as a useful tool for the prognostication of CLL patients. In our study we confirmed the significance of sFLC in CLL with regard to both treatment and overall survival and showed their relationship with adverse prognostic clinical and laboratory parameters.In an effort to identify other important disease markers, we studied the impact of BLyS and one of its receptors sTACI. B-Lymphocyte Stimulator is a member of the TNF superfamily mainly produced by myeloid cells, monocytes, dendritic cells and osteoclasts in the bone marrow .It is involved in normal or malignant B cell differentiation, proliferation, survival and immunoglobulin production. It may be proteolytically cleaved from the cell membrane and circulate as a soluble protein. TACI ( transmembrane activator and CAML interactor ) is one of the 3 BLyS ( BAFF ) receptors and it is expressed by T and B cells. Serum BLyS levels were found considerably low in CLL patients and their low concentration related to shorter time to first treatment and overall survival. It was suggested that low BLyS levels in aggressive CLL were reflecting its binding to its receptors on B-cell surface, sequestrating it from circulation. TACI can be shed from cell surface and circulate in its soluble form ( sTACI ). It was found in our study that sTACI concentrations at diagnosis is a powerfull prognostic marker, related to parameters of disease activity and stage and more importantly to time to first treatment and overall survival. This particular finding has never been mentioned in other studies, to the best of our knowledge.

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
2016

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Sarri, Aikaterini
  • Σαρρή, Αικατερίνη

Subjects

dc:subject × 13

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/39262

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Sarri, Aikaterini; Σαρρή, Αικατερίνη. Παράγοντες (πλην των κυτταρογενετικών) με σημασία για τη συμπεριφορά της Χ.Λ.Λ.. National and Kapodistrian University of Athens, 2016. http://hdl.handle.net/10442/hedi/39262